7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one

C26H27F3N8O3 — CID 155382242

IUPAC7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one
SMILES[H]/N=c1/n(Cc2cc3c(c(-c4cn(C)nc4C(F)(F)F)c2)OCCN([C@@H](C)c2cc(OC)ccn2)C3=O)cnn1C
InChIInChI=1S/C26H27F3N8O3/c1-15(21-11-17(39-4)5-6-31-21)37-7-8-40-22-18(20-13-34(2)33-23(20)26(27,28)29)9-16(10-19(22)24(37)38)12-36-14-32-35(3)25(36)30/h5-6,9-11,13-15,30H,7-8,12H2,1-4H3/b30-25+/t15-/m0/s1
InChIKeyCPXLIDPXYOKTPG-OFAXYGNPSA-N
MW556.55 g/mol
LogP3.17
Rot. Bonds6

About 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one

7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one (PubChem CID 155382242) has the molecular formula C26H27F3N8O3 and a molecular weight of 556.55 g/mol. Its IUPAC name is 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one.

Molecular Properties

Compound Name7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one
PubChem CID155382242
Molecular FormulaC26H27F3N8O3
Molecular Weight556.55 g/mol
Exact Mass556.22
IUPAC Name7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one
SMILES[H]/N=c1/n(Cc2cc3c(c(-c4cn(C)nc4C(F)(F)F)c2)OCCN([C@@H](C)c2cc(OC)ccn2)C3=O)cnn1C
InChIInChI=1S/C26H27F3N8O3/c1-15(21-11-17(39-4)5-6-31-21)37-7-8-40-22-18(20-13-34(2)33-23(20)26(27,28)29)9-16(10-19(22)24(37)38)12-36-14-32-35(3)25(36)30/h5-6,9-11,13-15,30H,7-8,12H2,1-4H3/b30-25+/t15-/m0/s1
InChIKeyCPXLIDPXYOKTPG-OFAXYGNPSA-N
XLogP3.17
TPSA116.08 Ų
H-Bond Donors1
H-Bond Acceptors10
Rotatable Bonds6
Heavy Atoms40
Complexity

Lipinski Rule of Five

1 violation

RuleValue
MW ≤ 500556.55
LogP ≤ 53.17
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 1010

Analyze 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one?
The IUPAC name of 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one (CID 155382242) is 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one.
What is the SMILES notation for 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one?
The canonical SMILES for 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one is [H]/N=c1/n(Cc2cc3c(c(-c4cn(C)nc4C(F)(F)F)c2)OCCN([C@@H](C)c2cc(OC)ccn2)C3=O)cnn1C.
What is the InChIKey of 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one?
The InChIKey is CPXLIDPXYOKTPG-OFAXYGNPSA-N. The full InChI is InChI=1S/C26H27F3N8O3/c1-15(21-11-17(39-4)5-6-31-21)37-7-8-40-22-18(20-13-34(2)33-23(20)26(27,28)29)9-16(10-19(22)24(37)38)12-36-14-32-35(3)25(36)30/h5-6,9-11,13-15,30H,7-8,12H2,1-4H3/b30-25+/t15-/m0/s1.
What are the key properties of 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one?
7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one has a molecular weight of 556.55 g/mol, XLogP of 3.17, 6 rotatable bonds, 1 hydrogen bond donors, and 10 hydrogen bond acceptors.
Where does this data come from?
All data for 7-[(5-imino-1-methyl-1,2,4-triazol-4-yl)methyl]-4-[(1S)-1-(4-methoxy-2-pyridinyl)ethyl]-9-[1-methyl-3-(trifluoromethyl)pyrazol-4-yl]-2,3-dihydro-1,4-benzoxazepin-5-one is sourced from PubChem (CID 155382242), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).